or
Bookmark and Share
Process for preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof
   
Document Number
US Patent 6207829
Issued Date
March 27, 2001
Link
Inventors
Map
Abstract
A process is provided for the preparation of a compound of formulae (IA) (sidenafil) and (IB) ##STR1## comprising reacting a compound of formula (IIA) and (IIB) respectively in the presence of .sup.-- OR, wherein R in the case of formation of compound (IA) is CH.sub.2 CH.sub.3 and R in the case of formation of compound (IB) is CH.sub.2 CH.sub.2 CH.sub.3, where X is a leaving group: ##STR2##
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
17
Comments:
no comments yet
Owner
Pfizer Inc. (New York, NY)
Published
March 27, 2001
Application Number
09/415,440
Filed
October 8, 1999
US Classification
544/262   544/336 544/360 544/366 546/1 548/364.1 548/364.7 548/371.4
Int'l Classification
C07D   487/00   (20060101)   C07D   487/04   (20060101)   C07D   295/26   (20060101)   C07D   295/00   (20060101)  
Examiner
Assistant Examiner
Priority Data
Oct 12, 1998 [GB] 9822238
USPTO Field of Search
544/262   544/336   544/360   544/366   546/1   548/364.1   548/364.7   548/371.4  
Related Patents
7595322 - Heterocyclic sulfonamides as modulators of cardiac sarcomeres - Owned by Cytokinetics, Inc. (South San Francisco, CA)

Certain substituted sulfonamide derivatives of Formula I selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure. ##STR00001##

6908923 - Compositions and methods for treating heart failure - Owned by Cytokinetics, Inc. (South San Francisco, CA)

Certain substituted benzamide derivatives of Formula I: ##STR1## selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.

7053094 - Compositions and methods for treating heart failure - Owned by Cytokinetics, Inc. (South San Francisco, CA)

Certain substituted benzamide derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.

6964957 - Fused pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting ERAB or HADH2 activity - Owned by Agouron Pharmaceuticals, Inc. (La Jolla, CA)

Pyrazole compounds represented by the formula: ##STR1## are described. The pyrazole compounds and pharmaceutical compositions containing them may be used in inhibiting ERAB or HADH2 activity and in treating ERAB, HADH2 or amyloid-.beta. mediated diseases and conditions.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us